Abstract
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
Cite
CITATION STYLE
APA
Collins, J. K., O’Sullivan, G. C., O’Mahony, L., & Shanahan, F. (2007). Bifidobacterium in the treatment of inflammatory disease. United States Patent, 2(12).
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free